时珍国医国药
時珍國醫國藥
시진국의국약
LISHIZHEN MEDICINE AND MATERIA MEDICA RESEARCH
2010年
3期
772-774
,共3页
翟海龙%雷丹琼%程震勇%胡敏
翟海龍%雷丹瓊%程震勇%鬍敏
적해룡%뢰단경%정진용%호민
CD_4~+CD_(25)~+调节性T细胞%肿瘤%免疫治疗
CD_4~+CD_(25)~+調節性T細胞%腫瘤%免疫治療
CD_4~+CD_(25)~+조절성T세포%종류%면역치료
CD_4~+CD_(25)~+ regulatory T cells%Tumor%Immunnotherapy
CD_4~+CD_(25)~+调节性T细胞(CD_4~+CD_(25)~+ regulatory T cells, CD_4~+CD_(25)~+ Tregs)可抑制机体对肿瘤的免疫应答,导致不利于肿瘤患者的对肿瘤的免疫耐受.以降低CD_4~+CD_(25)~+Tregs作用,增强对肿瘤的免疫应答为新策略的肿瘤免疫治疗探索已有初步进展.方法 包括去除CD_4~+CD_(25)~+Tregs、单克隆抗体、蛋白分子转移、阻断Tregs的迁移和分化、逆转Tregs的分化、阻断Tregs的功能、疫/瘤苗、将Tregs调控与其他治疗模式相组合、提升抑制效应细胞的阈值.
CD_4~+CD_(25)~+調節性T細胞(CD_4~+CD_(25)~+ regulatory T cells, CD_4~+CD_(25)~+ Tregs)可抑製機體對腫瘤的免疫應答,導緻不利于腫瘤患者的對腫瘤的免疫耐受.以降低CD_4~+CD_(25)~+Tregs作用,增彊對腫瘤的免疫應答為新策略的腫瘤免疫治療探索已有初步進展.方法 包括去除CD_4~+CD_(25)~+Tregs、單剋隆抗體、蛋白分子轉移、阻斷Tregs的遷移和分化、逆轉Tregs的分化、阻斷Tregs的功能、疫/瘤苗、將Tregs調控與其他治療模式相組閤、提升抑製效應細胞的閾值.
CD_4~+CD_(25)~+조절성T세포(CD_4~+CD_(25)~+ regulatory T cells, CD_4~+CD_(25)~+ Tregs)가억제궤체대종류적면역응답,도치불리우종류환자적대종류적면역내수.이강저CD_4~+CD_(25)~+Tregs작용,증강대종류적면역응답위신책략적종류면역치료탐색이유초보진전.방법 포괄거제CD_4~+CD_(25)~+Tregs、단극륭항체、단백분자전이、조단Tregs적천이화분화、역전Tregs적분화、조단Tregs적공능、역/류묘、장Tregs조공여기타치료모식상조합、제승억제효응세포적역치.
CD_4~+CD_(25)~+ regulatory T cells(CD_4~+CD_(25)~+ Tregs) can suppress the useful immune response against tumors, which lead to immune tolerance to tumors in tumor patients. The tumor immunotherapy based on the new strategy which decreases the function of CD_4~+CD_(25)~+ Tregs and enhances the immune response against tumors has been explored. The methods were consisted of the depletion of CD_4~+CD_(25)~+Tregs, monoclonal antibodies, protein molecule transfer, blocking Tregs trafficking and differentiation, subverting Tregs differentiation, blocking Tregs effector functions, vaccine, combining Treg management with other treatment modalities and raising suppressed effector cell threshold.